21508352

Source:http://linkedlifedata.com/resource/pubmed/id/21508352

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007600, umls-concept:C0019643, umls-concept:C0030274, umls-concept:C0334227, umls-concept:C0441655, umls-concept:C1514526, umls-concept:C2239176
pubmed:issue	4
pubmed:dateCreated	2011-4-21
pubmed:abstractText	To determine the phenotypic effects of belinostat (bel) and bortezomib (bor) against pancreatic cancer (PC) and hepatocellular cancer (HCC) cell lines.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8102988
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Boronic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3, http://linkedlifedata.com/resource/pubmed/chemical/Histone Deacetylase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxamic Acids, http://linkedlifedata.com/resource/pubmed/chemical/PXD101, http://linkedlifedata.com/resource/pubmed/chemical/Protease Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Proteasome Endopeptidase Complex, http://linkedlifedata.com/resource/pubmed/chemical/Pyrazines, http://linkedlifedata.com/resource/pubmed/chemical/bortezomib
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1791-7530
pubmed:author	pubmed-author:EckhardtS GSG, pubmed-author:KulikowskiG NGN, pubmed-author:MorelliM PMP, pubmed-author:PlateMM, pubmed-author:SerkovaN JNJ, pubmed-author:SpratlinJ LJL, pubmed-author:TentlerJ JJJ
pubmed:issnType	Electronic
pubmed:volume	31
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1093-103
pubmed:meshHeading	pubmed-meshheading:21508352-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:21508352-Apoptosis, pubmed-meshheading:21508352-Boronic Acids, pubmed-meshheading:21508352-Carcinoma, Hepatocellular, pubmed-meshheading:21508352-Caspase 3, pubmed-meshheading:21508352-Cell Line, Tumor, pubmed-meshheading:21508352-Drug Synergism, pubmed-meshheading:21508352-Histone Deacetylase Inhibitors, pubmed-meshheading:21508352-Humans, pubmed-meshheading:21508352-Hydroxamic Acids, pubmed-meshheading:21508352-Immunoblotting, pubmed-meshheading:21508352-Liver Neoplasms, pubmed-meshheading:21508352-Magnetic Resonance Spectroscopy, pubmed-meshheading:21508352-Metabolomics, pubmed-meshheading:21508352-Pancreatic Neoplasms, pubmed-meshheading:21508352-Protease Inhibitors, pubmed-meshheading:21508352-Proteasome Endopeptidase Complex, pubmed-meshheading:21508352-Pyrazines
pubmed:year	2011
pubmed:articleTitle	Synergistic activity of histone deacetylase and proteasome inhibition against pancreatic and hepatocellular cancer cell lines.
pubmed:affiliation	Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. jennifer.spratlin@albertahealthservices.ca
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't